Related Experiment Video
Updated: Jul 7, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
A role for caspase 2 and PIDD in the process of p53-mediated apoptosis
Nicole Baptiste-Okoh1, Anthony M Barsotti, Carol Prives
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Abstract:
When treated with some DNA-damaging agents, human tumor-derived H1299 cells expressing inducible versions of wild-type or mutant p53 with inactive transactivation domain I (p53(Q22/S23)) undergo apoptosis as evidenced by cytochrome c release, nuclear fragmentation, and sub-G1 DNA content. Apoptosis induced by p53(Q22/S23) is relatively slow, however, and key downstream effector caspases are not activated. Nevertheless, with either version of p53, caspase 2 activation is required for release of cytochrome c and cell death. Remarkably, although p53(Q22/S23) is known to be defective in transcriptional activation of numerous p53 target genes, it can induce expression of proapoptotic targets including PIDD and AIP1 at least to the same extent as wild-type p53. Furthermore, RNAi silencing of PIDD, previously shown to be required for caspase 2 activation, suppresses apoptosis by both wild-type p53 and p53(Q22/S23). Thus, the initial stage of DNA damage-facilitated, p53-mediated apoptosis occurs by a PIDD- and caspase 2-dependent mechanism, and p53's full transcriptional regulatory functions may be required only for events that are downstream of cytochrome c release.
Insights
DNA-damaging agents trigger apoptosis via p53, involving PIDD and caspase 2. This pathway is crucial for cytochrome c release and cell death, even with a defective p53 transactivation domain.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The tumor suppressor protein p53 plays a critical role in cellular responses to DNA damage.
- p53's transactivation domain is essential for regulating target gene expression and mediating apoptosis.
- Mutant p53 variants can retain or gain functions, impacting cancer progression and treatment response.
Purpose of the Study:
- To investigate the role of a p53 mutant with an inactive transactivation domain (p53(Q22/S23)) in DNA damage-induced apoptosis.
- To elucidate the specific molecular mechanisms and key mediators involved in p53-dependent apoptosis, particularly concerning caspase activation and target gene induction.
- To determine whether p53's transcriptional activity is fully required for initiating apoptosis or for downstream events.
Main Methods:
- Utilized human tumor-derived H1299 cells expressing inducible wild-type or mutant p53(Q22/S23).
- Applied DNA-damaging agents to induce apoptosis.
- Assessed apoptosis through cytochrome c release, nuclear fragmentation, and DNA content analysis.
- Investigated caspase activation, specifically caspase 2.
- Examined the expression of proapoptotic target genes like PIDD and AIP1.
- Employed RNA interference (RNAi) to silence PIDD and assess its impact on apoptosis.
Main Results:
- p53(Q22/S23) induced apoptosis, characterized by cytochrome c release, nuclear fragmentation, and sub-G1 DNA content, although at a slower rate than wild-type p53.
- Key downstream effector caspases were not activated, but caspase 2 activation was essential for cytochrome c release and cell death.
- Despite a defective transactivation domain, p53(Q22/S23) induced proapoptotic targets PIDD and AIP1 similarly to wild-type p53.
- Silencing PIDD using RNAi suppressed apoptosis induced by both wild-type p53 and p53(Q22/S23).
Conclusions:
- The initial phase of DNA damage-induced, p53-mediated apoptosis relies on a mechanism involving PIDD and caspase 2.
- Caspase 2 activation is a critical early event required for cytochrome c release and subsequent cell death.
- Full transcriptional regulatory functions of p53 may not be necessary for the initiation of apoptosis but rather for events occurring downstream of cytochrome c release.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Apoptosis
DNA Damage Can Stall the Cell Cycle

